Effect of standard nicotinamide in the prevention of type 1 diabetes in first degree relatives of persons with type 1 diabetes

Eduardo Cabrera‐Rode, Gisela Molina, Celeste Arranz, Manuel Vera, Pedro González, Rolando Suárez, Mirta Prieto, Saul Alejandro Padron, Rafael León, Juana Tillán,

Autoimmunity · 2006 · 30 citations · 36 references

Abstract

Type 1 diabetes prevention trial using standard nicotinamide is feasible but fails to prevent or delay the disease onset at the dose we used.

References

36